# Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction

> **NCT00119691** · PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 34 (actual)

## Conditions studied

- Congestive Heart Failure
- Renal Insufficiency

## Interventions

- **DRUG:** Nesiritide

## Key facts

- **NCT ID:** NCT00119691
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2013-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00119691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00119691, "Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00119691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*